Combining drug–disease and economic modelling to inform drug development decisions
- 15 November 2001
- journal article
- review article
- Published by Elsevier in Drug Discovery Today
- Vol. 6 (22) , 1165-1170
- https://doi.org/10.1016/s1359-6446(01)02014-1
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Electronic compliance monitoring in resistant hypertension: the basis for rational therapeutic decisionsJournal Of Hypertension, 2001
- Developing compliance instructions for drug labelingClinical Pharmacology & Therapeutics, 2000
- Steering a course through the technology mazeDrug Discovery Today, 2000
- Adherence to Protease Inhibitor Therapy and Outcomes in Patients with HIV InfectionAnnals of Internal Medicine, 2000
- Simulation of Clinical TrialsAnnual Review of Pharmacology and Toxicology, 2000
- MEDICATION COMPLIANCE AS A FEATURE IN DRUG DEVELOPMENTAnnual Review of Pharmacology and Toxicology, 1997